Appetite quiets down
Most patients notice cravings, snacking and food noise drop within days of starting.
Tirzepatide activates two receptors. GLP-1 tells your brain you're full and slows stomach emptying; GIP also helps regulate appetite and blood sugar. Brand-name tirzepatide is sold as Zepbound® and Mounjaro®. Compounded tirzepatide is prepared by a licensed compounding pharmacy and is not FDA-approved.
Six-month trajectories from clinical data of the underlying molecules. GLP-1 produces continued, compounding loss; lifestyle changes alone tend to plateau and rebound.
Every body is different. These are the patterns we see most often across thousands of women on this protocol.
Most patients notice cravings, snacking and food noise drop within days of starting.
Body-weight reduction starts showing up on the scale and in how clothes fit.
Steady weekly loss with provider-guided dose titration. Mood and energy stabilize.
Average 15–20% body weight reduction in clinical data, with maintenance protocols built in.
Quick health questionnaire — about 5 minutes. We use it to match you to the right medication and dose.
A US-licensed clinician reviews your full profile and either prescribes or comes back with a question.
Your medication arrives free of charge with everything you need to start. Provider support is included.
At Gala, compounded tirzepatide starts at $99 per month on the annual plan, billed once a year. Your exact price depends on your state, your dose and the plan you choose, and you see it before you pay. No insurance is needed. GLP-1 cost without insurance Does the GLP-1 price go up with the dose?
It has the same active ingredient, tirzepatide. Zepbound® and Mounjaro® are FDA-approved brand-name products from Eli Lilly. Compounded tirzepatide is prepared by a licensed compounding pharmacy for an individual prescription and is not FDA-approved, so the brand-name trial results cannot be assumed to apply to it.
Take the online assessment. A licensed provider reviews your health history and prescribes compounded tirzepatide only if it is appropriate for you. If prescribed, it ships to your home, and your care team stays available for questions and dose adjustments.
The most common are nausea, diarrhea, constipation and other digestive symptoms, mostly at the start and after a dose increase. Your provider starts you on a low dose and adjusts it over time. Tell your provider about any severe or persistent symptoms.
It comes from licensed compounding pharmacies and is not FDA-approved. A licensed provider reviews your full medical history before prescribing and follows you during treatment.